Methodology
How the edition was made: methods, the model card, the evidence cut and its age, the acceptance record and the glossary.
Contents
- ·Edition home
- ·Executive summary
- 1Neurotechnology is clinical hardware and a new class of personal data
- 2Key findings
- 3Systems and sectors at baseline
- 4Risks and capability
- 5Consumer neural data outside medical rules
- 6Readings from the other desks
- 7The 2027 agenda
- 8Systems in depth
- AMethodology
- A.1 Methods
- A.2 Model card, Neurotechnology System Model v0
- A.3 The baseline evidence cut
- A.4 Evidence age and coverage
- A.5 Evidence cards, two anchor sources
- A.6 Publication acceptance record
- A.7 Status words
- A.8 How the edition is made, released and corrected
- A.9 Glossary and abbreviations
- A.10 Technical annex
- BData appendix
- CReferences and record
- ·Complete edition, for print
A.1Methods
The global baseline uses published values and four simple derivations. Each is shown in full so that any reader can reproduce it.
| No. | Derivation | Calculation | Result |
|---|---|---|---|
| (1) | Ratio of median rate in2 to rate in1 | 78 ÷ 62 | about 1.3 times |
| (2) | Gap between1 and natural conversation as stated in1 | 160 ÷ 62 | about 2.6 times |
| (3) | Months from preprint to journal version of the accuracy study3 | December 2023 to August 2024 | 8 months |
| (4) | Share of the 2025 round in the reported pre-money valuation20 | 650 ÷ 9,000 | about 7% |
| Strength | Definition |
|---|---|
| STRONG | a disruption in the source system has historically changed the target system’s service or output within one season, in more than one region |
| MODERATE | an effect is documented but buffered or slower |
| WEAK | an effect is plausible but not documented at global scale |
| Label | Rule |
|---|---|
| Reported | value as issued by its source, with year |
| Inferred | reasoned from cited evidence; never a measurement |
| Estimated | Nexus analytical value with stated method |
| Scenario | conditional on stated assumptions |
| Expert input | structured editorial judgement awaiting evidence |
A.2Model card, Neurotechnology System Model v0
- Model ID
- MDL-XT20-NEURO · v0.1
- Purpose
- represent neurotechnology as clinical hardware and a source of neural data coupled to health, materials, finance, workforce and privacy
- Family
- graph-based system of systems
- Inputs
- the cited sources of this edition; no proprietary data
- Method
- expert-specified coupling strengths (STRONG · MODERATE · WEAK) from assessments and analogue events
- Validation
- none yet, first validation against federation evidence in 2027
- Uncertainty
- qualitative; strengths are hypotheses, not measurements
- Domain of validity
- global scale; not for asset-, site- or country-level use
- Reproducibility
- strength table and sources published in this edition
typed in v0
documented within one season
documented, buffered
plausible, undocumented
A.3The baseline evidence cut
Every Nexus edition is published from a frozen evidence cut. The global baseline cut is documentary: it pins the exact edition of every source cited. Federation cuts begin with the first national Foundry cuts in 2027.
- Cut ID
- DC-XTECH-NEURO-GLOBAL-2026-B0
- Type
- baseline documentary cut
- Resolution policy
- pinned · as of 30 September 2026
- Sources pinned
- 44 cited sources, each at the edition and access date in the references
- Model runs
- none at baseline, analytical values are stated with their method
- Digest
- computed at freeze and recorded in the publication record
- Supersedes
- nothing, first cut of the series
- Superseded by
- the 2027 neurotechnology annual cut
Lineage
- 01
source edition
- 02
pinned citation
- 03
finding
- 04
page
- 05
publication record
| Element | Baseline 2026 | 2027 global annual |
|---|---|---|
| Sources | cited global publications, pinned by edition | national, regional and sector cuts through one graph |
| Analysis | stated methods and editorial estimates | typed analysis specifications |
| Models | Neurotechnology System Model v0 specification | model runs with receipts |
| Findings | twelve baseline findings | findings re-bound to federation evidence |
| Review | five passes scheduled | five passes on the exact digest |
A.4Evidence age and coverage
A 2026 global edition rests on evidence observed in many different years. This page shows each time base, so that no single year label hides older evidence.
| Indicator | Observed | Released | Cadence | Next release |
|---|---|---|---|---|
| Speech decoding papers | 2023 | Aug 2023 | one-off | follow-up papers |
| Speech accuracy over time | 2023 preprint · 2024 journal | Dec 2023 · Aug 2024 | one-off | more participants |
| Brain-spine interface | 2023 | May 2023 | one-off | longer follow-up |
| Endovascular study | 2025 | Sep 2025 | one-off | peer-reviewed version |
| PRIME registry entry | 2026 | Jan 2026 | continuous | next update |
| US neural data bill | 2025 | Sep 2025 | per session | committee action |
| UNESCO Recommendation | 2025 | Nov 2025 | one-off | national uptake |
| Chinese implementation opinion | 2025 | Jul 2025 | periodic | 2027 milestones |
| System | Coverage | Thinnest dimension |
|---|---|---|
| Hardware | PARTIAL | failure rates on a common basis |
| Clinic | PARTIAL | outcomes beyond one year |
| Neural data | PARTIAL | consumer practices |
| Governance | PARTIAL | text of national laws |
| Investment | THIN | market size and public funding |
| Energy and heat | THIN | power and heat budgets |
| Skills | THIN | workforce numbers |
| Materials | THIN | dependence by platform |
| Field | Source that would fill it | Blocker |
|---|---|---|
| Power and heat budgets of implanted interfaces | device makers, regulators, peer-reviewed engineering papers | no figure retrieved; the search for heating and power limits returned no quantitative source |
| Market size on a common definition | industry statistics and audited company reports29 | trade sources give widely different figures by definition; none was opened |
| Clinical workforce for implantation, programming and follow-up | national statistics, professional bodies | not retrieved; capability rung stays LISTED |
| Long-term failure and explant rates across platforms | trial reports, registries, manufacturers | only one-year results read78; no common reporting |
| Number of participants implanted per company | company reports and registry updates132026 | company statement of 5 in June 2025; a January 2026 report of 21 is secondhand and unverified |
| Peer-reviewed results for company-announced devices | journals for each company claim1527 | company releases only; no paper located |
| Consumer neural data practices by company | regulators, advocacy and academic audits33 | report not opened; no figure used |
| Text of California, Montana and Connecticut neural data laws | state legislature sites2541 | California page returned an access error; the others not retrieved |
| Public funding totals for neurotechnology programmes | ministries, research councils | the national research programme budget page returned an access error |
| Electrode materials and fabrication dependence by platform | industry and trade statistics | only a 2018 materials roadmap abstract read23 |
| Status of the MIND Act after referral to committee | congressional record | status read from bill text and a release only |
| Reimbursement and access to implants by country | health ministries, insurers | not reviewed |
| Wearable and non-invasive interface deployment data | companies, regulators | one paper named from memory32; no figure used |
| Capability rungs beyond guidance and planning | agencies, hospitals, laboratories | not reviewed |
A.5Evidence cards, two anchor sources
Published in Nature 620 (2023) by a Stanford-led group. One-off study. Role: binds INF-001 and the speech tiles. Coverage: one participant with ALS and four intracortical arrays.
EVD-XT20-001
A high-performance speech neuroprosthesis1
Introduced in the US Senate in 2025 as S. 2925. One-off text. Role: binds GOV-009. Coverage: US federal study of neural data; status was committee referral.
EVD-XT20-002
MIND Act of 2025 bill text11
| Dimension | EVD-XT20-001 | EVD-XT20-002 |
|---|---|---|
| Completeness | one participant; 50-word and 125,000-word vocabularies | full bill text; later status not read |
| Timeliness | published online 23 August 2023 | introduced 2025 |
| Revision | single paper version | amendments possible in committee |
| Method transparency | methods and data in the paper | text public |
| External validation | peer review | legislative process |
Evidence cards to follow in 2027
A.6Publication acceptance record
Editorial self-check at evidence close. Every applicable item carries a disposition; the remaining items are review, approval and deposit.
| Group | Area | Items | Pass | N/A | Pending |
|---|---|---|---|---|---|
| D1 | Identity and scope | 8 | 8 | 0 | 0 |
| D2 | Source and data | 12 | 9 | 1 | 2 |
| D3 | Analysis and models | 12 | 3 | 8 | 1 |
| D4 | Findings and claims | 9 | 8 | 0 | 1 |
| D5 | Figures, tables, maps | 10 | 6 | 2 | 2 |
| D6 | Editorial and citations | 10 | 8 | 0 | 2 |
| D7 | Review and approval | 13 | 0 | 0 | 13 |
| D8 | Artefact and design | 12 | 7 | 0 | 5 |
| D9 | Registry and release | 9 | 0 | 0 | 9 |
Publication gate
- Conditions met
- 14 of 23 at evidence close
- Blocking problems
- none recorded
- Open conditions
- reviews, approval of the exact digest, deposit, registry pointer
Not applicable at baseline
- Model runs
- first runs in Q1 2027
- Maps
- plates in Q2 2027
- Waivers
- none
A.7Status words
| Status | What it means |
|---|---|
| Observed | Measured directly and published by the source. |
| Reported | Published statistics of an official or institutional source. |
| Declared | Stated by the body concerned; not independently measured. |
| Estimated | A Nexus estimate from cited evidence, with its method in Annex A. |
| Modelled | Produced by a stated model from cited inputs. |
| Inferred | Reasoned from cited evidence; not measured. |
| Forecast | A projection by the cited source. |
| Simulated | A simulation result under stated assumptions. |
| Scenario | A conditional statement under stated assumptions; never a prediction. |
| Expert input | Expert judgement, recorded with its basis. |
| Candidate | Proposed for a later edition; not yet evidence. |
| Evidence-quality levels (EQL 1 to 5) grade the source behind a value; they are not a score of the subject. | |
A.8How the edition is made, released and corrected
Every edition is built from a sealed evidence cut, reviewed under three keys, signed and deposited before any site shows it as published; corrections go to Nexus Standards as change proposals and feed the next cut.
| Step | What happens | Source |
|---|---|---|
| 01 Evidence arrives from the pillars | Foundry seals observations and indicator series, Universe hands over after-action and scenario findings, and contributions are screened at every gateway, including this site’s. | |
| 02 The cut is sealed | On the cut date the evidence is pinned under one identifier, so anyone can rebuild the edition from exactly what it was built on. | |
| 03 The edition is assembled | The edition is drafted from its template and content pack. Agents may draft; they never publish and never decide. | |
| 04 The keys turn | At the publisher of record the truth key comes first: every value is checked against its source or stated method before the meaning and capital keys turn. No edition moves on until every key has been turned by a named steward. | |
| 05 The gate opens | A named approver releases one exact digest of the edition; any change after this point is a new version, never a silent edit. | |
| 06 Signed and deposited | The PDF, the web edition and the data bundle are signed together with a manifest and an RO-Crate description, and deposited on Zenodo with a concept and a version DOI. | |
| 07 Published on its desk’s site | Only then does the edition show as published on its desk’s Reports site, and the Collection lists it as a part. | |
| 08 Corrections go to Standards | Method and correction findings go to Nexus Standards as change proposals; citations, corrections and new contributions feed the next evidence cut. |
A teaching model of the process, not a forecast and not a record of any run; dates and counts on this page come from the programme record. Sources: Reports governance at GCRI Canada (2026); Zenodo, repository of record for Reports deposits (2026).
Lifecycle, one state at a time: Draft, Computed, Evidence bound, Reviewed, Approved for release, Published, Corrected, Superseded. This edition is a draft.
A.9Glossary and abbreviations
| Term | Meaning |
|---|---|
| Baseline Edition | the inaugural annual edition that fixes the reference state for the series |
| WEFH+B | water, energy, food, health and biodiversity, the national nexus core |
| Coupling | a typed dependency through which one system transmits to another |
| Protection gap | the share of losses not covered by insurance |
| Capability ladder | LISTED → EXISTS → ADEQUATE → TESTED → DEMONSTRATED |
| EQL | evidence-quality level, 1–5 |
| Evidence cut | a frozen resolution of exact sources and versions |
| NNC · NLC · NWG | National Nexus Consortium · National Leadership Council · National Working Groups |
| Abbreviation | Expansion |
|---|---|
| ALS | amyotrophic lateral sclerosis |
| BCI | brain-computer interface |
| DBS | deep brain stimulation |
| EFS | early feasibility study |
| FDA | US Food and Drug Administration |
| FTC | US Federal Trade Commission |
| IDE | investigational device exemption |
| MIND | Management of Individuals Neural Data |
| MIIT | Ministry of Industry and Information Technology of China |
| PRIME | Precise Robotically Implanted Brain-Computer Interface study |
| UNESCO | United Nations Educational, Scientific and Cultural Organization |
| WER | word error rate |
A.10Technical annex
| Item | Annex | Contents | Status |
|---|---|---|---|
| A.1 | Indicator definitions | the global indicator set, with units and sources | IN THIS EDITION |
| A.2 | Coupling strengths | the twenty-cell matrix and its rationale | IN THIS EDITION |
| A.3 | Scenario specification | SCN-XT20-NDT-01 assumptions and signposts | IN THIS EDITION |
| A.4 | Capability placements | rung evidence for fifteen functions | IN THIS EDITION |
| A.5 | Model diagnostics | first runs and validation | 2027 |
| A.6 | Sensitivity analyses | influence of coupling strengths | 2027 |
| A.7 | Cluster notes | cards for the major clinical interface clusters | 2027 |
| A.8 | Review statements | pass-by-pass review record | AT RELEASE |
A.1 · indicator definition: word error rate
- Construct
- share of decoded words that differ from the words the participant intended to say
- Unit
- percent
- Method
- attempted speech decoded by a trained model from implanted electrode signals, scored against the intended sentences
- Source
- Nature 620 (2023)12
- Uncertainty
- as reported by the authors; not restated here
- Known limits
- one participant per study; sentences and vocabulary set by the researchers
Notes
Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references
- 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
- 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
- 29UNVERIFIED, not opened: market-research reports on the neurotechnology and brain-computer interface markets for 2025 (several firms; figures differ by a large factor depending on definition), taken from search-result summaries; weak evidence and no figure used. Observation year 2025. Accessed 2026-11-03.back
- 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
- 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
- 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
- 26UNVERIFIED, not opened: report of January 2026 that Neuralink was enrolling 21 participants worldwide, taken from a search-result summary of a secondhand news item citing people familiar with the matter; weak evidence. Observation year 2026. Accessed 2026-11-03.back
- 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
- 27UNVERIFIED, not opened: Paradromics (ed.), company statements on an FDA investigational device exemption for the Connect-One early feasibility study (November 2025, two initial participants) and a first implant at a university hospital, taken from search-result summaries of vendor announcements; weak evidence. Paradromics, Austin. Observation year 2025. Accessed 2026-11-03.back
- 33UNVERIFIED, not opened: Neurorights Foundation (ed.), report on privacy practices of consumer neurotechnology companies, 2024, cited from memory without figures; the foundation page returned not found. Neurorights Foundation, New York. Observation year 2024. Accessed 2026-11-03.back
- 25UNVERIFIED, not opened: California Senate Bill 1223 (Becker), consumer privacy: sensitive personal information: neural data, signed 27 September 2024, in force 1 January 2025, taken from search-result summaries; the legislature page returned an access error. California Legislature, Sacramento. Observation year 2024. Accessed 2026-11-03.back
- 41UNVERIFIED, not opened: Montana and Connecticut state laws on neural data, named in the Senate release [12] and in search-result summaries; texts not opened. State legislatures, Helena and Hartford. Observation year 2025. Accessed 2026-11-03.back
- 23Wellman, S.M. et al., A materials roadmap to functional neural interface design, Advanced Functional Materials 28(12), 2018 (reference record read; no figures in the abstract). Wiley, Weinheim. Observation year 2018. Accessed 2026-11-03.back
- 32UNVERIFIED, not opened: Meta Reality Labs research team, paper on a wrist-worn electromyography interface for generic human-computer interaction, Nature 2025, cited from memory; the Nature page redirected to an access check. Springer Nature, London. Observation year 2025. Accessed 2026-11-03.back
- 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back
